150 related articles for article (PubMed ID: 11804870)
1. Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery.
Clapp LH; Finney P; Turcato S; Tran S; Rubin LJ; Tinker A
Am J Respir Cell Mol Biol; 2002 Feb; 26(2):194-201. PubMed ID: 11804870
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1beta, transforming growth factor-beta1, and bradykinin attenuate cyclic AMP production by human pulmonary artery smooth muscle cells in response to prostacyclin analogues and prostaglandin E2 by cyclooxygenase-2 induction and downregulation of adenylyl cyclase isoforms 1, 2, and 4.
El-Haroun H; Bradbury D; Clayton A; Knox AJ
Circ Res; 2004 Feb; 94(3):353-61. PubMed ID: 14670842
[TBL] [Abstract][Full Text] [Related]
3. Prostacyclin analogues differentially inhibit growth of distal and proximal human pulmonary artery smooth muscle cells.
Wharton J; Davie N; Upton PD; Yacoub MH; Polak JM; Morrell NW
Circulation; 2000 Dec; 102(25):3130-6. PubMed ID: 11120706
[TBL] [Abstract][Full Text] [Related]
4. Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cells.
Growcott EJ; Spink KG; Ren X; Afzal S; Banner KH; Wharton J
Respir Res; 2006 Jan; 7(1):9. PubMed ID: 16423283
[TBL] [Abstract][Full Text] [Related]
5. Prostacyclin analogs as the brakes for pulmonary artery smooth muscle cell proliferation: is it sufficient to treat severe pulmonary hypertension?
Tuder RM; Zaiman AL
Am J Respir Cell Mol Biol; 2002 Feb; 26(2):171-4. PubMed ID: 11804866
[No Abstract] [Full Text] [Related]
6. Peroxisome proliferator-activated receptor-β/δ, the acute signaling factor in prostacyclin-induced pulmonary vasodilation.
Li Y; Connolly M; Nagaraj C; Tang B; Bálint Z; Popper H; Smolle-Juettner FM; Lindenmann J; Kwapiszewska G; Aaronson PI; Wohlkoenig C; Leithner K; Olschewski H; Olschewski A
Am J Respir Cell Mol Biol; 2012 Mar; 46(3):372-9. PubMed ID: 22021335
[TBL] [Abstract][Full Text] [Related]
7. Smooth muscle proliferation and role of the prostacyclin (IP) receptor in idiopathic pulmonary arterial hypertension.
Falcetti E; Hall SM; Phillips PG; Patel J; Morrell NW; Haworth SG; Clapp LH
Am J Respir Crit Care Med; 2010 Nov; 182(9):1161-70. PubMed ID: 20622039
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative effect of sildenafil on human pulmonary artery smooth muscle cells.
Tantini B; Manes A; Fiumana E; Pignatti C; Guarnieri C; Zannoli R; Branzi A; Galié N
Basic Res Cardiol; 2005 Mar; 100(2):131-8. PubMed ID: 15739122
[TBL] [Abstract][Full Text] [Related]
9. Dilator prostanoid-induced cyclic AMP formation and release by cerebral microvascular smooth muscle cells: inhibition by indomethacin.
Parfenova H; Hsu P; Leffler CW
J Pharmacol Exp Ther; 1995 Jan; 272(1):44-52. PubMed ID: 7529312
[TBL] [Abstract][Full Text] [Related]
10. Pentoxifylline inhibits PDGF-induced proliferation of and TGF-beta-stimulated collagen synthesis by vascular smooth muscle cells.
Chen YM; Wu KD; Tsai TJ; Hsieh BS
J Mol Cell Cardiol; 1999 Apr; 31(4):773-83. PubMed ID: 10329205
[TBL] [Abstract][Full Text] [Related]
11. The prostacyclin-mimetic cicaprost inhibits endogenous endothelin-1 release from human pulmonary artery smooth muscle cells.
Wort SJ; Mitchell JA; Woods M; Evans TW; Warner TD
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S410-3. PubMed ID: 11078436
[TBL] [Abstract][Full Text] [Related]
12. Effects of the adenylyl cyclase inhibitor SQ22536 on iloprost-induced vasorelaxation and cyclic AMP elevation in isolated guinea-pig aorta.
Turcato S; Clapp LH
Br J Pharmacol; 1999 Feb; 126(4):845-7. PubMed ID: 10193763
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effects of prostacyclin analogs and phosphodiesterase inhibitors on cyclic adenosine 3',5' monophosphate accumulation and adenosine 3'5' triphosphate release from human erythrocytes.
Knebel SM; Elrick MM; Bowles EA; Zdanovec AK; Stephenson AH; Ellsworth ML; Sprague RS
Exp Biol Med (Maywood); 2013 Sep; 238(9):1069-74. PubMed ID: 23986226
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of cicaprost-induced desensitization in rat pulmonary artery smooth muscle cells involves a PKA-mediated inhibition of adenylyl cyclase.
Sobolewski A; Jourdan KB; Upton PD; Long L; Morrell NW
Am J Physiol Lung Cell Mol Physiol; 2004 Aug; 287(2):L352-9. PubMed ID: 15107293
[TBL] [Abstract][Full Text] [Related]
15. Induction of hyaluronic acid synthase 2 (HAS2) in human vascular smooth muscle cells by vasodilatory prostaglandins.
Sussmann M; Sarbia M; Meyer-Kirchrath J; Nüsing RM; Schrör K; Fischer JW
Circ Res; 2004 Mar; 94(5):592-600. PubMed ID: 14752026
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of the single isomer, esuberaprost (beraprost-314d) on pulmonary vascular tone, IP receptors and human smooth muscle proliferation in pulmonary hypertension.
Shen L; Patel JA; Norel X; Moledina S; Whittle BJ; von Kessler K; Sista P; Clapp LH
Biochem Pharmacol; 2019 Aug; 166():242-252. PubMed ID: 31158340
[TBL] [Abstract][Full Text] [Related]
17. Endogenously released endothelin-1 from human pulmonary artery smooth muscle promotes cellular proliferation: relevance to pathogenesis of pulmonary hypertension and vascular remodeling.
Wort SJ; Woods M; Warner TD; Evans TW; Mitchell JA
Am J Respir Cell Mol Biol; 2001 Jul; 25(1):104-10. PubMed ID: 11472982
[TBL] [Abstract][Full Text] [Related]
18. Effects of prostacyclin analogs on the synthesis of tissue factor, tumor necrosis factor-alpha and interleukin-1 beta in human monocytic THP-1 cells.
Crutchley DJ; Conanan LB; Que BG
J Pharmacol Exp Ther; 1994 Oct; 271(1):446-51. PubMed ID: 7525928
[TBL] [Abstract][Full Text] [Related]
19. U-61,431F, a stable prostacyclin analogue, inhibits the proliferation of bovine vascular smooth muscle cells with little antiproliferative effect on endothelial cells.
Shirotani M; Yui Y; Hattori R; Kawai C
Prostaglandins; 1991 Feb; 41(2):97-110. PubMed ID: 1708156
[TBL] [Abstract][Full Text] [Related]
20. Relaxant actions of nonprostanoid prostacyclin mimetics on human pulmonary artery.
Jones RL; Qian YM; Wise H; Wong HN; Lam WL; Chan HW; Yim AP; Ho JK
J Cardiovasc Pharmacol; 1997 Apr; 29(4):525-35. PubMed ID: 9156364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
